Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2023
Jan. 31, 2023
Current assets:    
Cash and cash equivalents $ 13,790 $ 13,415
Marketable securities, available for sale, fair value 1,409 1,244
Accounts receivable, net of allowances for credit losses 7,362 10,382
Unbilled receivables, net of allowances for credit losses 8,354 7,757
Prepaid expenses and other current assets 2,834 2,314
Total current assets 33,749 35,112
Property and equipment, net 670 713
Operating lease right-of-use assets 1,215 1,360
Unbilled receivables, net of allowances for credit losses 4,659 5,044
Other assets 415 430
Total assets 40,708 42,659
Current liabilities:    
Accounts payable 1,852 1,541
Accrued expenses 2,352 3,813
Deferred revenue 5,087 5,172
Total current liabilities 9,291 10,526
Deferred revenue 92 130
Operating lease liabilities 489 691
Taxes payable 98 98
Other liabilities 3 3
Total liabilities 9,973 11,448
Commitments and contingencies (Note 5)
Stockholders' equity:    
Common stock, $0.01 par value per share; 100,000,000 shares authorized; 2,533,482 shares issued and 2,524,886 shares outstanding at April 30, 2023; 2,519,319 shares issued and 2,510,723 shares outstanding at January 31, 2023 25 25
Additional paid-in capital 267,481 267,120
Treasury stock, at cost; 8,596 shares at April 30, 2023 and January 31, 2023 (227) (227)
Accumulated other comprehensive loss (1,795) (1,890)
Accumulated deficit (234,749) (233,817)
Total stockholders' equity 30,735 31,211
Total liabilities and stockholders' equity $ 40,708 $ 42,659